Fatal cough syrup: UP firm 'linked' to 65 Uzbekistan children deaths to resume operations : The Tribune India

Join Whatsapp Channel

Fatal cough syrup: UP firm 'linked' to 65 Uzbekistan children deaths to resume operations

Fatal cough syrup: UP firm 'linked' to 65 Uzbekistan children deaths to resume operations

The Uttar Pradesh Government has permitted the resumption of most production at a factory owned by Marion Biotech, whose cough syrups Uzbekistan linked to the deaths of 65 children last year, according to an order seen by Reuters.



New Delhi, October 11

The Uttar Pradesh Government has permitted the resumption of most production at a factory owned by Marion Biotech, whose cough syrups Uzbekistan linked to the deaths of 65 children last year, according to an order seen by Reuters.

Fatal cough syrup

  • Marion Biotech in Uttar Pradesh allowed to resume production of most items
  • State says company cannot make products with propylene glycol
  • Plant yet to reopen pending inspections, other review, say sources

Marion is among three Indian companies whose cough syrups the World Health Organisation (WHO) and other agencies have linked to the deaths of 141 children in Uzbekistan, Gambia and Cameroon since the middle of last year, in one of the world’s worst such waves of poisoning.

“There’s no known case of a lack of quality in other medicines manufactured by the firm,” the drug controller of Uttar Pradesh where Marion is based, and which cancelled the firm’s licence in March, said in the September 14 order sent to the company. “Therefore, in view of natural justice, the appeal of the manufacturing firm is partially accepted. Its permission to make products using (cough syrup ingredient) propylene glycol is cancelled, and it is allowed to make and sell all other products.” The drug controller, Shashi Mohan Gupta, said in the order that the decision to allow the company to reopen its factory was taken by the state’s health department on August 11 after an appeal by the company.

Gupta declined to comment on the letter. He said that the Drugs Controller General of India, Rajeev Singh Raghuvanshi, had written to Marion Biotech to initiate a plan of corrective and preventive actions by the company. Raghuvanshi and the company did not respond to a request for comment. Marion, which says on its website it deals in pharmaceuticals, herbal and cosmetics products, has previously denied any wrongdoing.

Uttar Pradesh closed Marion’s factory after Uzbekistan’s Health Ministry found that two cough syrups made by Marion, Ambronol and DOK-1 Max, contained unacceptable amounts of toxins diethylene glycol (DEG) and ethylene glycol (EG), which are usually used in products not meant for human consumption.

Tests in January by an Indian government laboratory found 22 samples of Marion-made syrups were “adulterated and spurious”, the drug controller said in March. — Reuters


Top News

Pralhad Joshi moves motion in Lok Sabha for discussion on panel report seeking expulsion of Mahua Moitra

TMC MP Mahua Moitra expelled from Lok Sabha; Opposition terms it 'black chapter'

Ethics Committee of Lok Sabha had recommended Moitra's expul...

‘Hanged by a kangaroo court’: TMC's Mahua Moitra on her expulsion from Lok Sabha

'Hanged by a kangaroo court': TMC's Mahua Moitra on her expulsion from Lok Sabha

'Will fight you for next 30 years inside and outside Parliam...

BJP CM race: Rajnath Singh, ML Khattar, Arjun Munda lead BJP observer list for Rajasthan, MP, Chhattisgarh

BJP CM race: Rajnath Singh, ML Khattar, Arjun Munda lead BJP observers' list for Rajasthan, MP, Chhattisgarh

The observers will visit the states and give inputs to BJP p...

Rejected allegations of India’s involvement in any act of violence in Canada: Govt in Lok Sabha

Rejected allegations of India’s involvement in any act of violence in Canada: Govt in Lok Sabha

PM Trudeau has made explosive allegation of ‘potential’ invo...

RBI raises UPI payment limit to hospitals, educational institutions

RBI raises UPI payment limit to hospitals, educational institutions

Cap for e-mandates for recurring payments too hiked


Cities

View All